Imaging swallowing function and the mechanisms driving dysphagia in inclusion body myositis
Sporadic inclusion body myositis (IBM) is a progressive condition which commonly affects patients aged above 40. IBM does not respond to immunosuppression and no proven treatments are available. Up to 80% of patients develop some degree of swallowing impairment during the disease course. Dysphagia i...
Uloženo v:
| Vydáno v: | Clinical and experimental rheumatology Ročník 42; číslo 2; s. 425 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Italy
01.02.2024
|
| Témata: | |
| ISSN: | 0392-856X |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Sporadic inclusion body myositis (IBM) is a progressive condition which commonly affects patients aged above 40. IBM does not respond to immunosuppression and no proven treatments are available. Up to 80% of patients develop some degree of swallowing impairment during the disease course. Dysphagia is a source of marked morbidity in IBM and predisposes patients to life-threatening complications such as aspiration pneumonia. The pathophysiology behind dysphagia in IBM is not fully understood. Evidence from imaging demonstrates that impaired swallowing is predominantly underpinned by oropharyngeal deficits. Changes in cricopharyngeal physiology is thought to be an important factor influencing dysphagia in IBM. However, it is unclear whether this is secondary to structural changes within the cricopharyngeus itself or driven by impairment of the muscles promoting pharyngeal clearance. The approach to dysphagia in IBM patients is limited by a lack of validated instruments to reliably assess swallowing function and an absence of effective therapeutic interventions derived from controlled trials targeting dysphagia. Imaging modalities such as the video fluoroscopic swallowing study (VFSS) are commonly used to evaluate dysphagia in IBM. Whilst VFSS is a commonly used technique in clinical practice; cumulative radiation exposure with repeated testing can be a limitation. Alternative imaging techniques could be developed further as outcome measures for assessing swallowing.In this review, we provide an overview of imaging techniques used to assess swallowing and the insight provided from such investigations into the mechanisms behind dysphagia in IBM. We suggest future directions for evaluation and outcome measurement of dysphagia in this population. |
|---|---|
| AbstractList | Sporadic inclusion body myositis (IBM) is a progressive condition which commonly affects patients aged above 40. IBM does not respond to immunosuppression and no proven treatments are available. Up to 80% of patients develop some degree of swallowing impairment during the disease course. Dysphagia is a source of marked morbidity in IBM and predisposes patients to life-threatening complications such as aspiration pneumonia. The pathophysiology behind dysphagia in IBM is not fully understood. Evidence from imaging demonstrates that impaired swallowing is predominantly underpinned by oropharyngeal deficits. Changes in cricopharyngeal physiology is thought to be an important factor influencing dysphagia in IBM. However, it is unclear whether this is secondary to structural changes within the cricopharyngeus itself or driven by impairment of the muscles promoting pharyngeal clearance. The approach to dysphagia in IBM patients is limited by a lack of validated instruments to reliably assess swallowing function and an absence of effective therapeutic interventions derived from controlled trials targeting dysphagia. Imaging modalities such as the video fluoroscopic swallowing study (VFSS) are commonly used to evaluate dysphagia in IBM. Whilst VFSS is a commonly used technique in clinical practice; cumulative radiation exposure with repeated testing can be a limitation. Alternative imaging techniques could be developed further as outcome measures for assessing swallowing.In this review, we provide an overview of imaging techniques used to assess swallowing and the insight provided from such investigations into the mechanisms behind dysphagia in IBM. We suggest future directions for evaluation and outcome measurement of dysphagia in this population.Sporadic inclusion body myositis (IBM) is a progressive condition which commonly affects patients aged above 40. IBM does not respond to immunosuppression and no proven treatments are available. Up to 80% of patients develop some degree of swallowing impairment during the disease course. Dysphagia is a source of marked morbidity in IBM and predisposes patients to life-threatening complications such as aspiration pneumonia. The pathophysiology behind dysphagia in IBM is not fully understood. Evidence from imaging demonstrates that impaired swallowing is predominantly underpinned by oropharyngeal deficits. Changes in cricopharyngeal physiology is thought to be an important factor influencing dysphagia in IBM. However, it is unclear whether this is secondary to structural changes within the cricopharyngeus itself or driven by impairment of the muscles promoting pharyngeal clearance. The approach to dysphagia in IBM patients is limited by a lack of validated instruments to reliably assess swallowing function and an absence of effective therapeutic interventions derived from controlled trials targeting dysphagia. Imaging modalities such as the video fluoroscopic swallowing study (VFSS) are commonly used to evaluate dysphagia in IBM. Whilst VFSS is a commonly used technique in clinical practice; cumulative radiation exposure with repeated testing can be a limitation. Alternative imaging techniques could be developed further as outcome measures for assessing swallowing.In this review, we provide an overview of imaging techniques used to assess swallowing and the insight provided from such investigations into the mechanisms behind dysphagia in IBM. We suggest future directions for evaluation and outcome measurement of dysphagia in this population. Sporadic inclusion body myositis (IBM) is a progressive condition which commonly affects patients aged above 40. IBM does not respond to immunosuppression and no proven treatments are available. Up to 80% of patients develop some degree of swallowing impairment during the disease course. Dysphagia is a source of marked morbidity in IBM and predisposes patients to life-threatening complications such as aspiration pneumonia. The pathophysiology behind dysphagia in IBM is not fully understood. Evidence from imaging demonstrates that impaired swallowing is predominantly underpinned by oropharyngeal deficits. Changes in cricopharyngeal physiology is thought to be an important factor influencing dysphagia in IBM. However, it is unclear whether this is secondary to structural changes within the cricopharyngeus itself or driven by impairment of the muscles promoting pharyngeal clearance. The approach to dysphagia in IBM patients is limited by a lack of validated instruments to reliably assess swallowing function and an absence of effective therapeutic interventions derived from controlled trials targeting dysphagia. Imaging modalities such as the video fluoroscopic swallowing study (VFSS) are commonly used to evaluate dysphagia in IBM. Whilst VFSS is a commonly used technique in clinical practice; cumulative radiation exposure with repeated testing can be a limitation. Alternative imaging techniques could be developed further as outcome measures for assessing swallowing.In this review, we provide an overview of imaging techniques used to assess swallowing and the insight provided from such investigations into the mechanisms behind dysphagia in IBM. We suggest future directions for evaluation and outcome measurement of dysphagia in this population. |
| Author | Dimachkie, Mazen M Machado, Pedro M Salam, Sharfaraz Allen, Jodi Hanna, Michael G |
| Author_xml | – sequence: 1 givenname: Sharfaraz surname: Salam fullname: Salam, Sharfaraz organization: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK – sequence: 2 givenname: Jodi surname: Allen fullname: Allen, Jodi organization: Department of Therapy and Rehabilitation, The National Hospital for Neurosurgery, London, UK – sequence: 3 givenname: Mazen M surname: Dimachkie fullname: Dimachkie, Mazen M organization: Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA – sequence: 4 givenname: Michael G surname: Hanna fullname: Hanna, Michael G organization: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK – sequence: 5 givenname: Pedro M surname: Machado fullname: Machado, Pedro M email: p.machado@ucl.ac.uk organization: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK. p.machado@ucl.ac.uk |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38372730$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kEtLw0AAhPdQsQ_9C7JHL7H76CaboxQfhYIXBcFD2OyjWdlHmk1s8-9tscLAzOGbOcwcTEIMGgCI0QNjLKdL6WzQx7Zr9OBFH92yx0e6FxMwQ7QkGWf55xTMU_pGiOQsL67BlHJakIKiGfjaeLGzYQfTQTgXD-dohiB7GwMUQcG-0dBr2Yhgk09QdfbnzKgxtc2pKaANJ0k3pHOjjmqEfozJ9jbdgCsjXNK3F1-Aj-en9_Vrtn172awft5mkOeszrHFJeYmxQkVeKE4UIoQLViOBDMOEYVOylaAayxWmhBsjFMW1WVFkCo4kWYD7v922i_tBp77yNkntnAg6DqkiJeGM5wjzE3p3QYfaa1W1nfWiG6v_Q8gv7SNo9Q |
| CitedBy_id | crossref_primary_10_3389_fmed_2025_1533165 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.55563/clinexprheumatol/t1x3qa |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| ExternalDocumentID | 38372730 |
| Genre | Journal Article Review |
| GroupedDBID | --- 29B 53G 5GY 5RE 8RF AAFWJ AATUM ADBBV AENEX AEODN AFFNX ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CUY CVF DIK ECM EIF EJD F5P FRP NPM P2P P6G RVY SJN TR2 W2D XRB ZGI ZXP ~4P 7X8 |
| ID | FETCH-LOGICAL-c365t-1e1938911d0767d82d0228a5b0a0f51251f954a3e1c41328ffad31bf430f780c2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001343940900027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0392-856X |
| IngestDate | Wed Oct 01 17:04:59 EDT 2025 Mon Jul 21 05:57:44 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c365t-1e1938911d0767d82d0228a5b0a0f51251f954a3e1c41328ffad31bf430f780c2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://www.clinexprheumatol.org/article.asp?a=20624 |
| PMID | 38372730 |
| PQID | 2928586018 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2928586018 pubmed_primary_38372730 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-02-01 |
| PublicationDateYYYYMMDD | 2024-02-01 |
| PublicationDate_xml | – month: 02 year: 2024 text: 2024-02-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Italy |
| PublicationPlace_xml | – name: Italy |
| PublicationTitle | Clinical and experimental rheumatology |
| PublicationTitleAlternate | Clin Exp Rheumatol |
| PublicationYear | 2024 |
| SSID | ssj0026567 ssj0000684810 |
| Score | 2.4095504 |
| SecondaryResourceType | review_article |
| Snippet | Sporadic inclusion body myositis (IBM) is a progressive condition which commonly affects patients aged above 40. IBM does not respond to immunosuppression and... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 425 |
| SubjectTerms | Aged Deglutition - physiology Deglutition Disorders - diagnostic imaging Deglutition Disorders - etiology Diagnostic Imaging Disease Progression Humans Myositis, Inclusion Body - complications Myositis, Inclusion Body - diagnostic imaging |
| Title | Imaging swallowing function and the mechanisms driving dysphagia in inclusion body myositis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38372730 https://www.proquest.com/docview/2928586018 |
| Volume | 42 |
| WOSCitedRecordID | wos001343940900027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1LS8QwEICDL8SL78f6IoLXsmnTtOlJRFz04OJBoeBhyeaBC_axW9d1_70zbV1PgiCU0ksgTCeZLzOTGUIutRTaNy6ElZZwL-QWlpRm3BNDw1TCjE6YrptNxP2-TNPksXW4VW1a5feeWG_UptDoI-8GSSCFhOODvCrHHnaNwuhq20JjmaxyQBnU6jiVCx8Li7BYPFscwIBd6uvTwASeFFHaZPYIrJHVxYuI9rOcvNopoGLx1n33P_lY_Q6etQHqbf136ttks0VPet3oyg5ZsvkuWX9og-t75OU-q1sW0WqG0fgZfqLZw19HVW4osCLNLF4VHlVZRc1khN4IauZV-QojFR3l8Oi3KXrg6LAwc5rN66Swap88926fbu68tveCp3kk3j3fAtlJ2AkNi6PYyMBgoRwlhkwxJ5CKXCJCxa2vwQwG0jlluD90IWculkwHB2QlL3J7RGjEXOA0mEjsws4VIIkSNRgKLVjogg65-BbbAHQbAxYqt8W0GvwIrkMOG9kPyqYIxwBP1oBe7PgPo0_IRgAs0iRbn5JVByvbnpE1_QECmJzXSgPv_uPDFxsIzGE |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Imaging+swallowing+function+and+the+mechanisms+driving+dysphagia+in+inclusion+body+myositis&rft.jtitle=Clinical+and+experimental+rheumatology&rft.au=Salam%2C+Sharfaraz&rft.au=Allen%2C+Jodi&rft.au=Dimachkie%2C+Mazen+M&rft.au=Hanna%2C+Michael+G&rft.date=2024-02-01&rft.issn=0392-856X&rft.volume=42&rft.issue=2&rft.spage=425&rft_id=info:doi/10.55563%2Fclinexprheumatol%2Ft1x3qa&rft_id=info%3Apmid%2F38372730&rft_id=info%3Apmid%2F38372730&rft.externalDocID=38372730 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0392-856X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0392-856X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0392-856X&client=summon |